Open access

Research Article

20 October 2020

The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey

Authors: Eberhard Rabe https://orcid.org/0000-0002-2436-7697 [email protected], Catherine Régnier https://orcid.org/0000-0002-8293-862X, Fabienne Goron, Ghislaine Salmat, and Felizitas Pannier https://orcid.org/0000-0001-7399-5991Author Info & Affiliations

Publication: Journal of Comparative Effectiveness Research

Volume 9, Number 17

https://doi.org/10.2217/cer-2020-0158

PDF OtherFormats

Abstract

Aim: This study assessed the characteristics of individuals with chronic venous disease (CVD) and their treatment pathways. Materials & methods: A web-based survey enrolled representative populations of adults from Brazil, Czech Republic, France, Hungary, Italy, Romania, Russia and Spain, and identified those self-reporting CVD. Results: A total of 22% of respondents had signs/symptoms of CVD. Individuals with CVD were generally older, female and obese, and had more comorbidities than the general population. Common initial symptoms were tiredness, heaviness, pain, swelling in legs and night cramps. Participants waited ∼1 year before seeking treatment but most did not initially consult a physician; those who did tended to have more severe disease. Conclusion: One in five adults had CVD, but most did not seek a physician's help.

Supplementary Material

File (supplementary appendix.pdf)

Download
1.00 MB

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest

1.

Eklof B, Perrin M, Delis KT et al. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J. Vasc. Surg. 49(2), 498–501 (2009).

• The VEIN-TERM consensus document is intended to augment previous transatlantic/international interdisciplinary efforts in standardizing venous nomenclature.

2.

Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N. Engl. J. Med. 355(5), 488–498 (2006).

3.

Nicolaides A, Kakkos S, Baekgaard N et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int. Angiol. 37(3), 181–254 (2018).

•• Describes current concepts for chronic venous diseases (CVDs), updated guidelines for management and the strength of evidence supporting the recommendations.

4.

Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 130(4), 333–346 (2014).

• Reviews clinical aspects of chronic venous insufficiency (CVI), with a focus on the diagnostic and therapeutic options.

5.

Eklof B, Rutherford RB, Bergan JJ et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J. Vasc. Surg. 40(6), 1248–1252 (2004).

6.

Kuet ML, Lane TR, Anwar MA, Davies AH. Comparison of disease-specific quality of life tools in patients with chronic venous disease. Phlebology 29(10), 648–653 (2014).

7.

Launois R. Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs. J. Vasc. Surg. Venous Lymphat. Disord. 3(2), 219–227, e211–213 (2015).

•• This systematic review confirmed that CVDs have an important effect on QOL. The majority of the studies addressed the application rather than the validation of the ten identified scales.

8.

Rabe E, Pannier F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology 25(Suppl. 1), 64–67 (2010).

9.

Onida S, Davies AH. Predicted burden of venous disease. Phlebology 31(Suppl. 1), 74–79 (2016).

• Reviews the current and future burden of chronic venous disease from an epidemiological, quality of life and economic perspective.

10.

Dimakakos E, Syrigos K, Scliros E, Karaitianos I. Prevalence, risk and aggravating factors of chronic venous disease: an epidemiological survey of the general population of Greece. Phlebology 28(4), 184–190 (2013).

11.

Khan AF, Chaudhri R, Ashraf MA, Mazaffar MS, Zawar-Ul-Imam S, Tanveer M. Prevalence and presentation of chronic venous disease in Pakistan: a multicentre study. Phlebology 28(2), 74–79 (2013).

12.

Vuylsteke ME, Thomis S, Guillaume G, Modliszewski ML, Weides N, Staelens I. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur. J. Vasc. Endovasc. Surg. 49(4), 432–439 (2015).

13.

Zolotukhin IA, Seliverstov EI, Shevtsov YN et al. Prevalence and risk factors for chronic venous disease in the general Russian population. Eur. J. Vasc. Endovasc. Surg. 54(6), 752–758 (2017).

14.

Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F, Coordinators VCP. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int. Angiol. 31(2), 105–115 (2012).

•• The Vein Consult Program survey provides reliable results on CVD global epidemiology and shows that CVD affects a significant part of the populations worldwide, underlining the importance of adequate screening for CVD and training of both general practitioners (GPs) and specialist physicians.

15.

Daisie. http://adn-soft.com/daisie/

16.

Rabe E, Pannier F, Ko A, Berboth G, Hoffmann B, Hertel S. Incidence of varicose veins, chronic venous insufficiency, and progression of the disease in the Bonn Vein Study II. J. Vasc. Surg. 51(3), 791 (2010).

• Shows a high incidence of about 2% for varicose veins and for CVI per year. During the same time, the incidence of progression to higher C classes seems to be very high.

17.

Guex J-J, Rabe E, Escotto SI et al. The “C0s” patient: worldwide results from the Vein Consult Program. Phlebolymphology 19(4), 182–192 (2012).

18.

Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 318(7180), 353–356 (1999).

|